Skip to main content

Day: April 19, 2024

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)

Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira®The agreement broadens patient access and further commitment to availability of vital biologics in the U.S. and globallyREYKJAVIK, Iceland, April 19, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryvk in the U.S. market, the newly U.S. Food and Drug Administration (FDA) approved high-concentration interchangeable biosimilar to Humira. “This new partnership agreement supports our financial guidance...

Continue reading

Private Bancorp of America, Inc. Announces Strong Net Income and Earnings Per Share for First Quarter 2024

First Quarter 2024 HighlightsNet income for the first quarter of 2024 of $7.9 million, compared to $7.9 million in the prior quarter and $9.0 million in the first quarter of 2023. Net income for the first quarter of 2024 represents a return on average assets of 1.48% and a return on average tangible common equity of 16.86% Diluted earnings per share for the first quarter of 2024 of $1.36, compared to $1.36 in the prior quarter and $1.57 in the first quarter of 2023 Loans held-for-investment (“HFI”) totaled $1.91 billion as of March 31, 2024, an increase of $59.8 million or 3.2% (13.0% annualized) from December 31, 2023. Loans HFI increased 17.5% year over year Provision for credit losses for the first quarter of 2024 was $0.2 million, compared to $0.5 million for the prior quarter and $0.1 million for the first quarter of 2023. The allowance...

Continue reading

Bic: Annual Shareholders’ Meeting on May 29, 2024 – Publication of Meeting notice

  FOR IMMEDIATE RELEASE                         Annual Shareholders’ Meeting on May 29, 2024Publication of Meeting notice Clichy, France – April 19, 2024 – The Shareholders of SOCIÉTÉ BIC are invited to participate to the Combined (extraordinary and ordinary) Shareholders’ Meeting that will take place on Wednesday, May 29, 2024, at 9:00 a.m. Paris time at the Cloud Business Center – 10 bis, rue du 4 septembre, 75002 Paris, France. The related meeting notice (avis de réunion valant avis de convocation) has been published in the Bulletin des Annonces Légales Obligatoires (BALO1) on April 19, 2024, and includes the agenda, the draft text of the resolutions and the terms of participation and voting at this Annual Shareholders’ Meeting. Documents and information concerning the Annual Shareholders’ Meeting will be made available to shareholders...

Continue reading

Technip Energies Selected by Viridor to perform FEED on the Runcorn Energy-from-Waste Carbon Capture Project in the United Kingdom

Viridor Runcorn CCS©photography@bigcheese.co.uk 2024Technip Energies (PARIS:TE) has been awarded a Front-End Engineering Design (FEED) contract by Viridor for the Carbon Capture and Storage (CCS) project at one of the United Kingdom’s largest Energy-from-Waste facilities in Runcorn, United Kingdom. The project aims to capture around 900,000 tonnes of CO2 each year, half of which will be from biogenic sources, effectively removing 450,000 tonnes of CO2 annually from the atmosphere. As part of the FEED study, Technip Energies will deliver a comprehensive design utilising the Canopy by T.EN™ solution powered by Shell CANSOLV CO2 capture technology. The Canopy offering is part of Capture.Now™, Technip Energies’ strategic Carbon Capture, Utilization and Storage (CCUS) platform of technologies and solutions. The Runcorn...

Continue reading

Nykredit’s and Totalkredit’s auctions for 1 July 2024 refinancing – Totalkredit A/S

To Nasdaq Copenhagen                                                           19 April 2024    Nykredit’s and Totalkredit’s auctions for 1 July 2024 refinancingThe Nykredit Group plans to conduct auctions in the period from Tuesday May 21 to Friday May 24 2024. The auctions will comprise refinancing of adjustable-rate mortgages (”Tilpasningslån”) in DKK and floating-rate loans in DKK. The Nykredit Group currently expects to sell bonds totaling up to DKK 42bn. The amounts are preliminary and will be affected by prepayments and refinancing changes until end April. Time scheduleThe auctions will be held according to the following schedule.Auction period Expected auction times – CET21 to 24 May First auction: Bidding until 10:30 / allotment 10:40 at latestSecond auction: Bidding until 11:30 / allotment 11:40 at latestThird auction:...

Continue reading

Elanders AB: Quarterly Report January – March 2024

First quarter 2024Net sales amounted to MSEK 3,268 (3,589), which corresponded to an organic net sales reduction of nine percent, excluding acquisitions and discontinued operations, and using unchanged exchange rates. The reduction is primarily a result of a weaker market and lower freight rates and volumes in the Group’s Air & Sea freight forwarding operations. Adjusted EBITA amounted to MSEK 180 (217), which equaled an adjusted EBITA margin of 5.5 (6.0) percent. During the period, one-off items of MSEK -26 (-67) where charged to operating result. These mainly referred to acquisition costs. Adjusted net result amounted to MSEK 32 (77), corresponding to SEK 0.89 (2.16) per share. Operating cash flow adjusted for purchase prices for acquisitions increased to MSEK 641 (512). Operating cash flow including acquisitions amounted to MSEK...

Continue reading

Form 8.3 – International Distributions Services Plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Jupiter Fund Management Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of Offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree International Distributions Services plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date dealing undertaken:        For an...

Continue reading

Michelin: Publication of the preparatory documentation for the Annual Shareholders Meeting of May 17, 2024

Clermont-Ferrand, April 19, 2024 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Publication of the preparatory documentation for the Annual Shareholders Meeting of May 17, 2024 The Annual Meeting of Michelin Shareholders will be held on Friday, May 17, 2024 from 9 a.m. at the Zénith d’Auvergne, 24 rue de Sarliève, 63800 Cournon d’Auvergne, Puy-de-Dôme, France. As Michelin shares are exclusively registered shares, all shareholders receive a notice of meeting including a voting form, the Meeting agenda, the resolutions submitted to their approval, and the main terms and conditions for participating and voting. This document, as well as the preliminary notice of meeting published in the French journal of record, Bulletin des Annonces Légales Obligatoires, within the legal deadlines, are available on the website at https://www.michelin.com/en/investors/general-meetings Shareholders...

Continue reading

2023 annual results of the Groupama Group

Premium income (insurance premiums and other income) of €17.0 billion, up +6.9%Strong growth in property and casualty insurance (+10.7%), driven by the solid performance of international subsidiaries Increase in premium income in health and protection insurance (+7.9%) Decrease in the savings/pensions business (-4.4%)Net income of €510 millionEconomic operating income of €627 million, despite an elevated climate-related claims charge (€1.3 billion before reinsurance) Combined non-life ratio of 96.8%Solvency ratio of 197% without transitional measureSolvency ratio of 267% without transitional measure on technical reserves Group’s IFRS equity of €9.9 billion, up +€1.1 billion Contractual services margin of €3.6 billion“Groupama’s results for 2023 show its great resilience. I would like to salute the unwavering commitment of our...

Continue reading

QPR Software Plc Interim report January–March 2024

QPR SOFTWARE PLC             STOCK EXCHANGE RELEASE          19 April 2024, AT 9.00 AM EETQPR Software Plc’s interim report for January-March 2024: SaaS- and software net sales increased. The company’s turnaround is progressing according to the strategy, and the first partnership agreements were signed in North America.FINANCIAL DEVELOPMENT BRIEFLY JANUARY-MARCH 2024SaaS net sales increased by +15% Software net sales increased by +4% Net sales was 1,769 thousand euros, down -21% (January-March 2023: 2, 237) due to company’s discontinuation of consulting outside the core business. EBITDA was 295 thousand euros (-36), a difference of 332 thousand euros from the comparison period The operating profit was 33 thousand euros (-287), a difference 320 thousand euros from the comparison period   Profit before taxes was 13...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.